Where does Medmix Systems AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medmix Systems AG ranks #17,888 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medmix Systems AG hold?

Medmix Systems AG holds 16 US utility patents granted between 2015 and 2018, spanning 11 technology areas.

What is Medmix Systems AG's Innovation Score?

Medmix Systems AG has an Innovation Score of 31.7 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medmix Systems AG focus on?

Medmix Systems AG's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Medmix Systems AG's patent grant rate increasing or decreasing?

Medmix Systems AG's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Medmix Systems AG's patents?

Medmix Systems AG's patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medmix Systems AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medmix Systems AG

USPTO PatentsView assignee record - 16 granted patents across 11 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medmix ranks #17,888 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 11 technology areas.

#17,888
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.7/100): 17.0
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17888 · Foreign Corporation #17,888 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,888/49,997
PHOTO-FINISH Marel Salmon A/S
CPC-FOCUS A61B · 11 areas
INNOV-THIN 31.7/100
CLAIMS-RICH 17.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Marel Salmon A/S (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medmix’s 31.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (31%) Velocity 0.0 pts (0%) Breadth 11.7 pts (37%) Claim depth 10.2 pts (32%)

Qualcomm Incorporated · highest

85
Medmix Systems · this assignee

32
3D Lighting… · lowest

7

What this shows Medmix's Innovation Score is 31.7/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medmix?

Each dot is one of Medmix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medmix’s own 17.0 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medmix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medmix's grants concentrate

Medmix Systems AG is a focused PatentsView assignee: 11 CPC subclasses with 68.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (8 grants) versus a trough of 1 in 2018. By volume, Medmix sits between Marel Salmon A/S and Mercer University.

Marel Salmon A/S

16
Marvel Technology…

16
Matisa Matériel I…

16
Matroid

16
Megvii (Beijing)…

16
Melfas

16
Mems Drive (Nanji…

16
Mercer University

16
Medmix Systems ◀

16

What this shows Medmix holds 16 patents at rank #17,872, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medmix

By rank, the assignees closest to #17,872 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medmix's primary technology class.

Medmix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medmix Systems AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	50.0%
2016	5	31.3%
2017	2	12.5%
2018	1	6.3%

Which technologies does Medmix Systems AG patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 7

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

B05C - Apparatus FOR Applying Fluent Materials TO Surfaces, IN General 5

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 4

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 4

B67B - Applying Closure Members TO Bottles Jars, OR Similar CONTAINERS; Opening Closed Containers 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 3

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medmix Systems AG's patent record in context - here's where to go next.

Medmix Systems AG's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 68.8% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #17,888 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medmix Systems AG against Marel Salmon A/S, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.